PHARMAKO BIOTECHNOLOGIES
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

PHARMAKO BIOTECHNOLOGIES Trademark

Serial Number: 79181451 • Registration: 5139421

PHARMAKO BIOTECHNOLOGIES is a trademark filed by Pharmako Biotechnologies Pty Limited on September 11, 2015. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Pharmako Biotechnologies Pty Limited (13 trademarks)

2/2 Aquatic Dr

Entity Type: 82

Trademark Details

Filing Date

September 11, 2015

Registration Date

February 14, 2017

Published for Opposition

November 29, 2016

Goods & Services

[ Biological preparations for laboratory purposes other than for medical or veterinary use; ] active chemical ingredients for use in the manufacture of drugs; chemical preparations for use in the production of drugs

Pharmaceutical and veterinary preparations for treating nutritional deficiencies; bioactive compounds in the nature of pharmaceutical excipients, namely, lipid agents; chemical products in the nature of lipid based excipients for use in biotechnology for medical [ or veterinary ] use, namely, for the treatment and assistance of health and well-being, gastrointestinal absorption, brain and cognitive function, cardiovascular health, joint and articular health [, libido and virility ]; chemical products, namely, lipophilic substances in the nature of excipients for the treatment and assistance of health and well-being, gastrointestinal absorption, brain and cognitive function, cardiovascular health, joint and articular health [, libido and virility ]; chemical reagents for medical [ or veterinary ] use; herbal supplements for medicinal use; plant extracts for use as dietary supplements for medicinal purposes for the treatment and assistance of health and well-being, namely, gastrointestinal absorption, brain and cognitive function, cardiovascular health, joint and articular health [, libido and virility ]; [ biological preparations in the nature of bioactive nutrients for pharmaceutical purposes; ] biological substances in the nature of a drug delivery system comprising of lipid-based oral tablets or capsules for the continuous release of therapeutic agents for medical use; [ reagents for use in biological processing for medical purposes; ] dietary supplements for humans and animals; dietetic food supplements, namely, capsules and tablets adapted for medical use for the treatment and assistance of health and well-being, gastrointestinal absorption, brain and cognitive function, cardiovascular health, joint and articular health [, libido and virility ]; [ nutritional meal replacement bars adapted for medical purposes; ] nutritional supplements for medical purposes; natural pharmaceutical products, namely, medicated cosmetics, dietary supplements, and food supplements produced from natural sources without added artificial ingredients in the form of beverages, capsules, tablets and powdered preparations; pharmaceutical products, namely, pharmaceutical lotions for the skin; products isolated or purified from foods and sold in medicinal forms that have a physiological benefit or provide protection against chronic disease, namely, nutraceuticals for the treatment of gastrointestinal absorption, brain and cognitive function, cardiovascular health, joint and articular health [, libido and virility ]; preparations in the nature of medicines for treating skin disorders; preparations in the nature of medicines to aid gastrointestinal absorption and for the treatment of gastrointestinal absorption, brain and cognitive function, cardiovascular health, joint and articular health [, libido and virility ]; pharmaceutical preparations for skin care; medicated skincare preparations, namely, medicinal creams for the protection of the skin; dietary supplement beverages adapted for medicinal purposes for the treatment and assistance of health and well-being, gastrointestinal absorption, brain and cognitive function, cardiovascular health, joint and articular health [, libido and virility; nutritional meal replacements, namely, dietary food supplements in the nature of beverages, capsules, tablets and powdered preparations; health food supplements, namely, products isolated or purified from foods and sold in medicinal forms that have a physiological benefit for the treatment and assistance of health and well-being, namely, gastrointestinal absorption, brain and cognitive function, cardiovascular health, joint and articular health, libido and virility; medicinal oils; medicinal ointments ]

Scientific and technological services, namely, research and design in the field of nutraceuticals, pharmaceuticals, cosmeceuticals and functional foods; industrial research in the field of cosmeceuticals; [ biotechnology research; ]biotechnology testing, namely, testing of nutraceuticals, [ pharmaceuticals, ] cosmeceuticals and functional foods; [ research relating to biotechnology; ] scientific research services; testing, analysis and evaluation for the purpose of assessing the efficiency of chemicals, [ consumer products, ] pharmaceuticals and veterinary drugs to assure compliance with industry standards; [ advisory services relating to biochemistry; ] chemical research; chemical laboratory services; chemical analysis; [ biochemical engineering services; biochemistry research services; biological research; ] scientific laboratory services in the field of nutraceuticals, [ pharmaceuticals, ] cosmeceuticals and functional foods; product development; providing information, including online, about scientific and technological services, namely, research and design in the field of nutraceuticals, [ pharmaceuticals, ] cosmeceuticals and functional foods; [ research relating to pharmaceuticals; ] research relating to biotechnology; scientific research relating to chemical products; scientific research relating to cosmetics; testing of chemicals; testing, analysis and evaluation of nutraceuticals, [ pharmaceuticals, ]cosmeceuticals and functional foods to assure compliance with industry standards

Filing History

COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
Feb 15, 2026 REM4
INTERNATIONAL REGISTRATION RENEWED
Oct 9, 2025 RNWL
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Apr 17, 2023 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Apr 17, 2023 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 1, 2023 APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 28, 2023 APRE
TEAS SECTION 71 & 15 RECEIVED
Feb 14, 2023 ES75
NEW REPRESENTATIVE AT IB RECEIVED
Sep 17, 2022 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 8, 2022 ADCH
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Feb 14, 2022 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Oct 25, 2019 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Apr 11, 2019 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Jun 23, 2017 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jun 1, 2017 FICS
FINAL DISPOSITION PROCESSED
Jun 1, 2017 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 14, 2017 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 14, 2017 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 29, 2016 NPUB
PUBLISHED FOR OPPOSITION
Nov 29, 2016 PUBO
NEW REPRESENTATIVE AT IB RECEIVED
Nov 17, 2016 NREP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 9, 2016 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Oct 27, 2016 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 25, 2016 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 24, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 24, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 24, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 24, 2016 CNEA
EXAMINER'S AMENDMENT ENTERED
Oct 24, 2016 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 24, 2016 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 24, 2016 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 24, 2016 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 7, 2016 GNFN
FINAL REFUSAL E-MAILED
Jul 7, 2016 GNFR
FINAL REFUSAL WRITTEN
Jul 7, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 21, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 21, 2016 CRFA
ASSIGNED TO LIE
Jun 15, 2016 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 8, 2016 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 31, 2016 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 31, 2016 REAP
REFUSAL PROCESSED BY IB
Mar 11, 2016 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 22, 2016 RFCS
REFUSAL PROCESSED BY MPU
Feb 22, 2016 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 18, 2016 RFCR
NON-FINAL ACTION WRITTEN
Feb 17, 2016 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Feb 9, 2016 RFWR
APPLICATION FILING RECEIPT MAILED
Feb 9, 2016 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 7, 2016 RFCR
NON-FINAL ACTION WRITTEN
Feb 6, 2016 CNRT
ASSIGNED TO EXAMINER
Feb 5, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 5, 2016 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 4, 2016 REPR